PURE Bioscience, Inc. PURE
0.07 USD 0.00 -4.00%
As of Nov 2, 2:12 PM ET
- Open
- 0.07
- Prev close
- 0.075
- Mkt cap
- 10.09M
- Vol
- 34.02K
- Avg vol
- 29.29K
- EPS
- -0.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0621
- High
- 0.072
- Forward P/E
- 0.00
- Beta
- -1.99
- Short ratio
- 2.56
- Inst. own
- 2.50%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.02
- 200-d avg
- 1.03
- 1y target
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for PURE has not been loaded yet. Try again in a moment.
Altman Z-Score
-172.32 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -3.0×
P/S 3.2×
P/B -1.2×
P/FCF -4.3×
EV/EBITDA -6.5×
EV/Sales 5.8×
FCF Yield -23.3%
Gross Margin 57.2%
Operating Margin -89.9%
Net Margin -107.1%
ROE 38.8%
ROIC -1026.1%
ROA -208.1%
Revenue 5.3%
Operating Income 8.3%
EPS (diluted) 0.5%
Free Cash Flow 13.7%
Current Ratio 0.3×
Quick Ratio 0.2×
Debt / Equity -1.0×
Net Debt / EBITDA -2.9×
Interest Coverage -5.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-07-31